老年肺癌术后长期生存预测模型:STS-GTSD-Medicare 分析
研究将 STS 普胸数据库与 Medicare 数据链接,纳入 2002–2013 年 29,899 例 65 岁以上肺癌切除患者,构建长期生存 Cox 模型。模型区分度 C 统计量为 0.694,校准良好;年龄与病理分期是最强预测因子,楔形/肺段/双肺叶/全肺切除较肺叶切除死亡风险更高,胸腔镜入路较长切口长期生存更优。
要点
- 年龄与病理分期是老年肺癌术后长期生存最强预测因子
- 校正分期后,楔形、肺段、双肺叶及全肺切除较肺叶切除死亡风险更高
- 胸腔镜入路较长切口与长期生存改善相关
核心结论
- STS-GTSD-Medicare 长期风险模型包含多个与死亡率相关的新因素,校准良好且 C 统计量为 0.694。
- 年龄和病理分期是最强长期生存预测因子,但手术方式与胸腔镜/开胸入路为可干预的预测因素。
研究设计与样本
- 将 STS 普胸数据库与 Medicare 数据链接,纳入 2002–2013 年 65 岁以上肺癌切除患者 29,899 例。
- 采用 Cox 比例风险模型构建长期生存模型,变量选择基于单因素显著因素及已知临床预测因素。
- 校准通过按预测生存十分位分组评估,区分度用 C 统计量经 1,000 次 bootstrap 重复校正乐观度。
主要发现
- 中位年龄 73 岁(四分位距 68–78 岁),男性占 48%。
- 29,094 例有病理分期的患者中,I 期 69%、II 期 18%、III 期 11%、IV 期 2%。
- 手术方式:肺叶切除 69%、双肺叶切除 3%、全肺切除 3%、肺段切除 7%、袖状肺叶切除 1%、楔形切除 17%。
- 胸腔镜入路占 47%。
- 校正分期后,楔形切除、肺段切除、双肺叶切除和全肺切除均与较肺叶切除更高的死亡风险相关;胸腔镜入路较长切口与长期生存改善相关;其他可干预预测因素包括吸烟和低体重指数。
临床怎么用
- 对 65 岁以上肺癌切除患者,可参考该模型纳入年龄、病理分期、手术方式、入路、吸烟和体重指数评估长期生存风险。
- 在条件允许时优先选择肺叶切除而非楔形、肺段、双肺叶或全肺切除,并优先考虑胸腔镜入路以改善长期生存。
- 将吸烟和低体重指数作为可干预因素纳入术前评估与术后管理。
局限性
- 模型基于 STS-GTSD 与 Medicare 链接数据,仅纳入 65 岁以上患者。
- 原文未报告外部验证结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prior risk models using the STS General Thoracic Surgery database (STS-GTSD) have been limited to 30-day outcomes. We have now linked STS data to Medicare data and sought to create a risk prediction model for long-term mortality after lung cancer resection in patients older than 65 years. METHODS: The STS-GTSD was linked to Medicare data for lung cancer resections from 2002 to 2013 as previously reported. Successful linkage was performed in 29,899 lung cancer resection patients. Cox proportional hazards modeling was used to create a long-term survival model. Variable selection was performed using statistically significant univariate factors and known clinical predictors of outcome. Calibration was assessed by dividing the cohort into deciles of predicted survival and discrimination assessed with a C-statistic corrected for optimism via 1,000 bootstrap replications. RESULTS: Median age was 73 years (interquartile range, 68 to 78 years), and 48% of the patients were male. Of the 29,094 patients with nonmissing pathologic stage, 69% were stage I, 18% stage II, 11% stage III, and 2% stage IV. Procedure performed was lobectomy in 69%, bilobectomy in 3%, pneumonectomy in 3%, segmentectomy in 7%, sleeve lobectomy in 1%, and wedge resection in 17%. Thoracoscopic approach was performed in 47% of resections. The final Cox model reveals that stage and age are the strongest predictors of long-term survival. Even after controlling for stage, wedge resection, segmentectomy, bilobectomy, and pneumonectomy are all associated with increased hazard of death in comparison with lobectomy. Thoracoscopic approach is associated with improved long-term survival in comparison with thoracotomy. Other modifiable predictive factors include smoking and low body mass index. Calibration of the model demonstrates excellent performance across all survival deciles and a C-statistic of 0.694. CONCLUSIONS: The STS-GTSD-Medicare long-term risk model includes several novel factors associated with mortality. Although medical factors predict long-term survival, age and stage are the strong predictors. Despite this, procedure choice and thoracoscopic/open approach are potentially modifiable predictors of long-term survival after lung cancer resection.
引用
- Onaitis MW, Furnary AP, Kosinski AS, et al. Prediction of Long-Term Survival After Lung Cancer Surgery for Elderly Patients in The Society of Thoracic Surgeons General Thoracic Surgery Database. Ann Thorac Surg. 2017. PMID: 29174391. doi:10.1016/j.athoracsur.2017.06.071
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。